Skip to content

Functional Changes and Fall Risk in Older Adults Participating in a Frailty Program

Observational Study of Functional Changes and Fall Risk in Older Adults Participating in a Multicomponent Frailty and Falls Prevention Program in Primary Care

Status
Enrolling by invitation
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07572851
Acronym
FRAIL-ALAMA
Enrollment
56
Registered
2026-05-07
Start date
2026-04-02
Completion date
2026-07-30
Last updated
2026-05-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fall Risk, Frail Elderly

Keywords

Frailty, Falls prevention, Older adults, Physical function, SPPB, Sit-to-Stand, Primary care physiotherapy

Brief summary

This prospective observational study aims to describe changes in physical function and fall risk in adults aged 70 years and older participating in a routine multicomponent frailty and falls prevention program in primary care. Participants are evaluated before and after the intervention, and additional postural control variables are recorded using a pressure platform without modifying routine clinical care.

Detailed description

Frailty is a clinical condition associated with increased vulnerability to adverse health outcomes, including falls, disability, and mortality. In the Galician public health system, a structured frailty and falls prevention program is implemented within primary care physiotherapy services. This study is designed as a prospective, longitudinal observational study with pre-post evaluation under real-world clinical conditions, without modifying clinical decision-making or healthcare organization. Participants aged 70 years and older enrolled in the routine program undergo baseline (T0) and post-intervention (T1) assessments after 8 weeks. The intervention consists of a multicomponent exercise program including strength, balance, and functional training. The primary objective is to describe changes in physical function and fall risk. Secondary objectives include the characterization of participants, analysis of adherence, recording of adverse events, and evaluation of the feasibility and utility of pressure-platform-based balance assessment. Additional functional variables (muscle strength, aerobic capacity, and clinical balance tests) are included as part of the standardized functional assessment protocol implemented in routine care.

Interventions

OTHERMulticomponent Exercise Program- 1 times per week.

Group-based therapeutic exercise program lasting 8 weeks, including strength, functional, and aerobic training, delivered 1 times per week.

OTHERMulticomponent Exercise Program- 2 times per week.

Group-based therapeutic exercise program lasting 8 weeks, including strength, functional, and aerobic training, delivered 2 times per week.

Sponsors

University of Vigo
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
70 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥70 years * Barthel Index ≥90 * Participation in the frailty program * Ability to provide informed consent

Exclusion criteria

* Medical contraindication to exercise

Design outcomes

Primary

MeasureTime frameDescription
Change in Instrumented Balance: Center of Pressure (CoP) Sway AreaBaseline (T0) and post-intervention (8-12 weeks)-Change in Center of Pressure (CoP) Sway Area Change in postural sway area measured using a pressure platform. The Center of Pressure (CoP) sway area represents the area covered by the CoP trajectory during quiet standing. Unit of measure: square millimeters (mm²). Higher values indicate worse postural stability. Minimum value: 0 mm² Maximum value: Not applicable (no fixed upper limit) Interpretation: Higher values indicate worse postural stability
Change in Instrumented Balance: Center of Pressure (CoP) VelocityBaseline (T0) and post-intervention (8-12 weeks)Change in Center of Pressure (CoP) Velocity Change in mean velocity of center of pressure displacement. • Unit of measure: mm/s Minimum value: 0 mm/s Maximum value: Not applicable (no fixed upper limit) Interpretation: Higher values indicate worse postural stability
Change in Instrumented Balance:Center of Pressure (CoP) Path Length.Baseline (T0) and post-intervention (8-12 weeks)Change in Center of Pressure (CoP) Path Length Change in total trajectory length of center of pressure. • Unit of measure: mm Minimum value: 0 mm Maximum value: Not applicable (no fixed upper limit) Interpretation: Higher values indicate worse postural stability
Change in Physical Performance Short Physical Performance Battery (SPPB)Baseline (T0) and post-intervention (8-12 weeks)Change in Short Physical Performance Battery (SPPB) total score. The SPPB is a composite measure of lower extremity function including balance, gait speed, and chair stand tests. * Score range: 0 to 12 * Interpretation: Higher scores indicate better physical performance * Unit of measure: Points on a scale
Change in Fall RiskBaseline (T0) and post-intervention (8-12 weeks)Change in fall risk indicators based on clinical assessment (falls history and gait impairment). Minimum value: 0 Maximum value: Not applicable (composite clinical indicator; upper bound not fixed) Interpretation: Higher values indicate worse outcome (greater fall risk)

Secondary

MeasureTime frameDescription
Functional Performance: Change in Timed Up and Go (TUG) TestBaseline (T0) and post-intervention (8-12 weeks)Time required to stand up, walk 3 meters, turn, return, and sit down. * Unit of measure: Seconds * Interpretation: Lower values indicate better performance The interpretation of TUG results depends on the population (healthy adults, older adults, clinical populations), but general reference thresholds are as follows: * Older Adults (Community-Dwelling) \< 12 seconds: Normal functional mobility 12-20 seconds: Mild impairment / increased risk of functional decline \> 20 seconds: Significant mobility impairment * Fall Risk Interpretation \> 13.5 seconds: Increased risk of falls (commonly used cut-off) Clinical Populations (frail patients) 20-30 seconds: Moderate functional limitation \> 30 seconds: Severe dependency in mobility A change of approximately ≥ 2-3 seconds is often considered clinically meaningful, depending on the population studied.
Functional Performance: Change in Gait Speed (4-Meter Walk Test)Baseline (T0) and post-intervention (8-12 weeks)Change in usual walking speed assessed over a 4-meter distance. Gait speed is calculated as distance divided by time and expressed in meters per second (m/s). Only gait speed is reported as the outcome measure. Unit of measure: meters per second (m/s). Higher values indicate better functional performance. Minimum value: 0 m/s Maximum value: Not applicable (no fixed upper limit; typically \< 2.5 m/s in adults) Interpretation: Higher values indicate better functional performance
Functional Performance: Change in FRAIL Scale ScoreBaseline (T0) and post-intervention (8-12 weeks)Assessment of frailty status using the FRAIL scale. * Score range: 0 to 5 * Interpretation: Higher scores indicate greater frailty * Unit of measure: Points on a scale
Muscle Strength: Change in Handgrip StrengthBaseline (T0) and post-intervention (8-12 weeks)Assessment of maximal isometric grip strength using a dynamometer. * Unit of measure: kg (or Newtons, depending on device) * Interpretation: Higher values indicate greater strength
Muscle Strength: Change in 30-Second Sit-to-Stand TestBaseline (T0) and post-intervention (8-12 weeks)* Unit of measure: Repetitions * Interpretation: Higher values indicate better lower limb strength
BalanceBaseline (T0) and post-intervention (8-12 weeks)Unipodal stance or Functional Reach Test
Aerobic CapacityBaseline (T0) and post-intervention (8-12 weeks)2-Minute Step Test

Countries

Spain

Contacts

PRINCIPAL_INVESTIGATORLorenzo Justo-Cousiño, PhD

Department of Functional Biology and Health Sciences, Faculty of Physiotherapy, University of Vigo, Pontevedra, Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 8, 2026